NASDAQ NMS - GLOBAL MARKET · PYPD
+0.62% · +$0.0300 · Vol 144.1K
Market closed · last close 4:00 PM ET · price as of 16:00:00 ET
PolyPid Ltd

PolyPid Ltd

Pharmaceuticals
$4.84
Card
Relationship Map

Veridion Score

BETALOW CONF · 4/6 factorsMethodology
PYPD
PolyPid Ltd
Sat Aug 8 · market closed · Markets closed · resumes Mon 9:30 ET
BUY BIAS

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

65/ 100
Veridion Score
BUY BIAS · LOW confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 4/6 factors with data · Sat Aug 8 · market closed · Markets closed · resumes Mon 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is PYPD moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading PYPD catalysts
About PolyPid Ltd
Pharmaceuticals
Listed since
2020
Employees
75
Country
IL

PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. The company's product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$4.90
Day high
$4.99
Day low
$4.78
Previous close
$4.81
52W high
$5.58
-13.26% from high
52W low
$3.15
70% of range
Market cap
$92.8M
EPS
$-1.9113
Beta
0.62
Shares out
19.2M
Volume
144.1K
0.48× rel vol
Avg volume
301.6K
VWAP
$4.86
Price history computed in-house
1W
+12.82%
1M
-10.70%
3M
+10.50%
1Y
+50.31%
YTD
+11.52%
SMA 50 $4.74 · above
SMA 200 $4.37 · above
52W position 70%

PYPD overview

Veridion Score
65
4 of 6 factors measured
Congress receipts
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around PYPD.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading PYPD Form 4 filings
Public disclosures

Congress activity in PYPD

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for PYPD in the cached public ledger.

Federal contracts

PYPD contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for PYPD in this window.
Lobbying spend

PYPD lobbying filings, year to date.

Registered lobbying filings matched to PolyPid Ltd.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for PYPD in this window.
Loading news for PYPD
Analyst ratings
Sovereign unlock shows live analyst consensus for PYPD.
Options
Sovereign unlock shows live options positioning for PYPD.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.